Skip to main content
. 1999 Mar 2;96(5):1921–1926. doi: 10.1073/pnas.96.5.1921

Table 1.

Percentage of TGR-1 fibroblast nuclei containing ssDNA foci

Treatment % Nuclei with ssDNA foci
Total <10 Foci >10 Foci
None 1 <1 <1
None 2 1 1
None 2 1 1
Denaturation 93 11 82
Cycloheximide (10 μg/ml) (for 1 hr) 2 1 1
Actinomycin D (100 ng/ml) (for 1 hr) 3 1 2
Etoposide (0.5 μg/ml) (for 1 hr) 32 23 9
Etoposide (2 μg/ml) (for 1 hr) 43 29 14
Etoposide (6 μg/ml) (for 1 hr) 57 33 24
Etoposide (20 μg/ml) (for 1 hr) 61 15 46
MMC (0.5 μg/ml) (for 1 hr) 36 12 24
3 hr after MMC 27 11 16
6 hr after MMC 33 14 19
15 hr after MMC 29 5 24
24 hr after MMC 32 11 21
48 hr after MMC 13 1 12
1 hr after 0.5 Gy 21 16 5
1 hr after 1 Gy 36 26 10
1 hr after 2 Gy 40 20 20
1 hr after 5 Gy 45 25 20
1 hr after 10 Gy 49 15 34
6 hr after 1 Gy 22 13 9
6 hr after 5 Gy 25 14 11
24 hr after 0.5 Gy 10 3 7
24 hr after 1 Gy 14 7 7
24 hr after 2 Gy 15 6 9
24 hr after 5 Gy 21 10 11
24 hr after 10 Gy 30 16 14

At least 300 nuclei were analyzed for each experiment.